151157-48-1 Usage
General Description
1-(2-Fluorophenyl)cyclobutanecarboxylic acid is a chemical compound that has a cyclobutanecarboxylic acid core with a fluorophenyl group attached to it. It is commonly used as a building block in organic synthesis and pharmaceutical research. The compound has potential therapeutic applications due to its ability to interact with biological systems and modulate specific pathways. It may also be used as a precursor in the synthesis of various pharmaceuticals and other organic compounds. Additionally, its unique structure and properties make it a valuable tool for studying chemical reactions and investigating the behavior of cyclobutane-containing molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 151157-48-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,1,1,5 and 7 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 151157-48:
(8*1)+(7*5)+(6*1)+(5*1)+(4*5)+(3*7)+(2*4)+(1*8)=111
111 % 10 = 1
So 151157-48-1 is a valid CAS Registry Number.
151157-48-1Relevant articles and documents
Synthesis method of arylcyclobutane compound
-
Paragraph 0130-0133, (2022/01/10)
The present invention discloses a method for synthesizing an arylcyclobutane compound to 1eq phenylacetonitrile and 1.1eq 1-bromo-3-chloropropane as raw material, N,N- dimethylacetamide as a solvent, plus 2.5eq sodium hydride, under the protection of iner
Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
-
, (2008/06/13)
PCT No. PCT/SE97/01310 Sec. 371 Date Apr. 12, 1999 Sec. 102(e) Date Apr. 12, 1999 PCT Filed Jul. 23, 1997 PCT Pub. No. WO98/04517 PCT Pub. Date Feb. 5, 1998This invention relates to the use of 2-(diisopropylamino)-ethyl-1-phenyl-cyclopentane-carboxylate or 2-(diisopropylamino)-ethyl-1-phenyl-cyclohexane-carboxylate, or a pharmaceutically accceptable salt thereof, for treatment of urinary incontinence or irritable bowel syndrome (IBS).